New grant aims to transform treatment for liver cancer

Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term effects are limited.

Seattle institute lands $18m funding to develop RNA vaccine for chikungunya – Pharmaceutical Technology

There are currently no approved treatments for chikungunya, a mosquito-borne viral disease. Image credit: Shutterstock/mycteria. In a bid to support the development of thermostable RNA

August 3, 2023

Zombie Investments: The State of Private Equity in Healthcare

Greg Hagood, President of SOLIC Capital, LLC Private equity (PE) firms, once eager investors in the healthcare services sector, are facing a chilling reality. A

October 22, 2024

Study suggests high levels of vitamin B3 breakdown products are linked to higher risk of mortality, heart attacks, and stroke

Researchers utilized an untargeted metabolomics technique to look for new compounds and pathways that may contribute to residual cardiovascular disease risk.

February 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.